Trials / Not Yet Recruiting
Not Yet RecruitingNCT07015255
Assessing the Burden of Respiratory Syncytial Virus (RSV)
Assessing the Burden of Respiratory Syncytial Virus (RSV): the Assessment of the Burden of Respiratory Syncytial Virus (RSV) Across Different Age Groups and Risk Factors
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Abu Dhabi Health Services Company · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand: * How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV
Detailed description
This study is designed to analyze the impact of Respiratory Syncytial Virus (RSV) across different age groups. It focuses on how often RSV occurs, who is most at risk, and its long-term and financial effects. The study uses existing hospital records from SEHA facilities between January 2018 and December 2024. This is a retrospective observational study, meaning no new tests or treatments are given. Researchers look at medical records from past patients who were diagnosed with RSV. Anonymized data is collected from SEHA's Electronic Medical Records (EMR) and laboratory systems. Only patients with confirmed RSV infections are included.
Conditions
- Respiratory Syncytial Virus (RSV) Infection
- Acute Lower Respiratory Tract Infections
- Bronchiolitis
- Pneumonia
- Chronic Respiratory Conditions
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-06-11
- Last updated
- 2025-06-19
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT07015255. Inclusion in this directory is not an endorsement.